Annual Total Debt:
$638.85M+$52.81M(+9.01%)Summary
- As of today (September 17, 2025), PCRX annual total debt is $638.85 million, with the most recent change of +$52.81 million (+9.01%) on December 31, 2024.
- During the last 3 years, PCRX annual total debt has fallen by -$490.00 million (-43.41%).
- PCRX annual total debt is now -43.41% below its all-time high of $1.13 billion, reached on December 31, 2021.
Performance
PCRX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$631.40M-$5.06M(-0.79%)Summary
- As of today (September 17, 2025), PCRX quarterly total debt is $631.40 million, with the most recent change of -$5.06 million (-0.79%) on June 30, 2025.
- Over the past year, PCRX quarterly total debt has dropped by -$17.19 million (-2.65%).
- PCRX quarterly total debt is now -44.07% below its all-time high of $1.13 billion, reached on December 31, 2021.
Performance
PCRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
PCRX Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.0% | -2.6% |
| 3 y3 years | -43.4% | -24.1% |
| 5 y5 years | +81.5% | +59.6% |
PCRX Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.4% | +9.0% | -24.1% | +8.5% |
| 5 y | 5-year | -43.4% | +81.5% | -44.1% | +59.6% |
| alltime | all time | -43.4% | >+9999.0% | -44.1% | >+9999.0% |
PCRX Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $631.40M(-0.8%) |
| Mar 2025 | - | $636.46M(-0.4%) |
| Dec 2024 | $638.85M(+9.0%) | $638.85M(-0.9%) |
| Sep 2024 | - | $644.42M(-0.6%) |
| Jun 2024 | - | $648.60M(+11.5%) |
| Mar 2024 | - | $581.78M(-0.7%) |
| Dec 2023 | $586.04M(-23.2%) | $586.04M(-0.7%) |
| Sep 2023 | - | $590.30M(-4.9%) |
| Jun 2023 | - | $620.71M(-0.7%) |
| Mar 2023 | - | $625.16M(-18.1%) |
| Dec 2022 | $763.39M(-32.4%) | $763.39M(-7.1%) |
| Sep 2022 | - | $821.64M(-1.2%) |
| Jun 2022 | - | $831.36M(-17.0%) |
| Mar 2022 | - | $1.00B(-11.3%) |
| Dec 2021 | $1.13B(+108.6%) | $1.13B(+103.6%) |
| Sep 2021 | - | $554.56M(+1.0%) |
| Jun 2021 | - | $549.27M(+0.9%) |
| Mar 2021 | - | $544.15M(+0.6%) |
| Dec 2020 | $541.13M(+53.8%) | $541.13M(+0.9%) |
| Sep 2020 | - | $536.37M(+35.6%) |
| Jun 2020 | - | $395.69M(+11.7%) |
| Mar 2020 | - | $354.24M(+0.7%) |
| Dec 2019 | $351.92M(+21.0%) | $351.92M(+1.7%) |
| Sep 2019 | - | $346.01M(+0.8%) |
| Jun 2019 | - | $343.40M(+4.3%) |
| Mar 2019 | - | $329.24M(+13.2%) |
| Dec 2018 | $290.93M(+5.2%) | $290.93M(+1.3%) |
| Sep 2018 | - | $287.23M(+1.3%) |
| Jun 2018 | - | $283.59M(+1.3%) |
| Mar 2018 | - | $280.01M(+1.3%) |
| Dec 2017 | $276.50M | $276.50M(+1.3%) |
| Sep 2017 | - | $273.04M(+1.3%) |
| Jun 2017 | - | $269.65M(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $266.75M(+145.3%) |
| Dec 2016 | $108.74M(+4.5%) | $108.74M(+1.1%) |
| Sep 2016 | - | $107.56M(+1.1%) |
| Jun 2016 | - | $106.39M(+1.1%) |
| Mar 2016 | - | $105.22M(-0.7%) |
| Dec 2015 | $104.04M(+0.6%) | $105.93M(+1.0%) |
| Sep 2015 | - | $104.91M(+1.0%) |
| Jun 2015 | - | $103.89M(-0.2%) |
| Mar 2015 | - | $104.14M(+0.7%) |
| Dec 2014 | $103.38M(+3.2%) | $103.38M(+0.7%) |
| Sep 2014 | - | $102.67M(+0.8%) |
| Jun 2014 | - | $101.90M(+0.8%) |
| Mar 2014 | - | $101.06M(+0.9%) |
| Dec 2013 | $100.21M(+272.9%) | $100.21M(+0.9%) |
| Sep 2013 | - | $99.27M(+0.9%) |
| Jun 2013 | - | $98.37M(+1.0%) |
| Mar 2013 | - | $97.43M(+262.6%) |
| Dec 2012 | $26.87M(-5.2%) | $26.87M(+0.8%) |
| Sep 2012 | - | $26.65M(-1.7%) |
| Jun 2012 | - | $27.10M(-2.0%) |
| Mar 2012 | - | $27.66M(-2.4%) |
| Dec 2011 | $28.33M(-64.3%) | $28.33M(-1.0%) |
| Sep 2011 | - | $28.61M(-1.0%) |
| Jun 2011 | - | $28.91M(-2.5%) |
| Mar 2011 | - | $29.63M(-62.7%) |
| Dec 2010 | $79.42M(+189.6%) | $79.42M(+153.7%) |
| Sep 2010 | - | $31.30M(+456.5%) |
| Jun 2010 | - | $5.63M(>+9900.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $27.42M(>+9900.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00 |
| Dec 2008 | $0.00(0.0%) | - |
| Dec 2007 | $0.00 | - |
FAQ
- What is Pacira BioSciences, Inc. annual total debt?
- What is the all time high annual total debt for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual total debt year-on-year change?
- What is Pacira BioSciences, Inc. quarterly total debt?
- What is the all time high quarterly total debt for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly total debt year-on-year change?
What is Pacira BioSciences, Inc. annual total debt?
The current annual total debt of PCRX is $638.85M
What is the all time high annual total debt for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual total debt is $1.13B
What is Pacira BioSciences, Inc. annual total debt year-on-year change?
Over the past year, PCRX annual total debt has changed by +$52.81M (+9.01%)
What is Pacira BioSciences, Inc. quarterly total debt?
The current quarterly total debt of PCRX is $631.40M
What is the all time high quarterly total debt for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly total debt is $1.13B
What is Pacira BioSciences, Inc. quarterly total debt year-on-year change?
Over the past year, PCRX quarterly total debt has changed by -$17.19M (-2.65%)